Compare RMT & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RMT | IRWD |
|---|---|---|
| Founded | 1993 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 460.2M | 520.6M |
| IPO Year | N/A | 2010 |
| Metric | RMT | IRWD |
|---|---|---|
| Price | $11.57 | $5.26 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $5.74 |
| AVG Volume (30 Days) | 111.5K | ★ 7.5M |
| Earning Date | 01-01-0001 | 02-26-2026 |
| Dividend Yield | ★ 7.37% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.49 | 0.18 |
| Revenue | N/A | ★ $338,987,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $37.22 |
| P/E Ratio | ★ $6.18 | $29.53 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.67 | $0.53 |
| 52 Week High | $9.51 | $5.78 |
| Indicator | RMT | IRWD |
|---|---|---|
| Relative Strength Index (RSI) | 66.38 | 71.76 |
| Support Level | $11.36 | $4.17 |
| Resistance Level | $11.88 | $5.57 |
| Average True Range (ATR) | 0.18 | 0.39 |
| MACD | 0.05 | 0.09 |
| Stochastic Oscillator | 77.25 | 80.53 |
Royce Micro-Cap Trust Inc is a diversified closed-end investment company. The company is engaged in investing in micro-cap securities. It invests in the consumer discretionary sector including auto components, automobiles, diversified consumer services, hotels, restaurants and leisure, household durables, internet and catalog retail, leisure products, media, multiline retail, textiles, apparels, and luxury goods, Consumer staples sector including beverages, food, and staples retailing, food products, and personal products, Energy sector including energy equipment and services, and oil, gas, and consumable fuels. The company also invests in other sectors including healthcare, financials, industrials, IT, telecommunications, and materials.
Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.